Medications for COVID-19 Symptoms
For symptomatic relief of mild COVID-19, use acetaminophen (paracetamol) for fever and pain, maintain adequate hydration (no more than 2 liters daily), and use simple linctus or honey for cough; if you are high-risk (elderly, immunocompromised, or have significant comorbidities), initiate nirmatrelvir-ritonavir within 5 days of symptom onset to prevent progression to severe disease. 1, 2, 3
Symptomatic Treatment for Mild COVID-19
Fever and Pain Management
- Acetaminophen (paracetamol) is the preferred antipyretic and analgesic for managing fever and associated symptoms in COVID-19 patients 2, 3
- Use antipyretics only while fever and associated symptoms persist, not solely to reduce body temperature 2
- NSAIDs (ibuprofen, naproxen) can also be used for symptom control, though acetaminophen is generally preferred 3, 4
Cough Management
- Use simple linctus or honey for symptomatic relief of cough 2, 3
- Reserve codeine linctus, codeine phosphate tablets, or morphine sulfate oral solution only if cough is distressing and not controlled by simpler measures 2, 5
Hydration
Antiviral Therapy for High-Risk Patients
If you have risk factors for severe COVID-19 (age >65, obesity, diabetes, heart disease, lung disease, immunosuppression), you need antiviral therapy within 5 days of symptom onset, not just symptomatic treatment. 1, 2, 3
First-Line Antiviral: Nirmatrelvir-Ritonavir (Paxlovid)
- Nirmatrelvir-ritonavir is the preferred first-line antiviral for high-risk patients with mild COVID-19 1, 3, 6
- Dosage: 300 mg nirmatrelvir (two 150 mg tablets) with 100 mg ritonavir (one 100 mg tablet), taken together twice daily for 5 days 6
- Must be initiated within 5 days of symptom onset 1, 6
- Take at approximately the same time each day, with or without food 6
- Complete the full 5-day course even if feeling better 2
Critical drug interaction warning: Nirmatrelvir-ritonavir includes ritonavir, a strong CYP3A inhibitor that can cause potentially severe, life-threatening, or fatal interactions with many common medications 6. Review all current medications before prescribing, including supplements and herbal products 2, 6.
Dose Adjustments for Kidney Disease
- Moderate renal impairment (eGFR 30-60 mL/min): 150 mg nirmatrelvir with 100 mg ritonavir twice daily for 5 days 6
- Severe renal impairment (eGFR <30 mL/min): 300 mg nirmatrelvir with 100 mg ritonavir once on day 1, then 150 mg nirmatrelvir with 100 mg ritonavir once daily on days 2-5 6
Alternative Antiviral: Molnupiravir
- Molnupiravir should be considered only when nirmatrelvir-ritonavir is contraindicated or unavailable 1, 3
- Molnupiravir is less effective than nirmatrelvir-ritonavir and should be used with caution only if no other therapeutic options are acceptable 7
Alternative Antiviral: Remdesivir
- Remdesivir (3-day course) can be considered for high-risk outpatients within 7 days of symptom onset, particularly when drug interactions preclude nirmatrelvir-ritonavir use 2, 7
What NOT to Use
Corticosteroids
Do not use corticosteroids (dexamethasone, prednisone) for mild COVID-19 unless you already take them for another condition. 2, 3, 5 Corticosteroids are harmful in patients not requiring oxygen and should be reserved only for those with hypoxemia 2, 5.
Ineffective or Harmful Medications
- Do not use hydroxychloroquine - it increases risk of death and invasive mechanical ventilation without improving outcomes 1, 2, 5
- Do not use ivermectin - no evidence of benefit 1, 3
- Do not use sotrovimab - not effective against current variants 1, 3
- Do not use lopinavir-ritonavir - no clinical benefit and high adverse event rate 2, 5
Antibiotics
- Do not use antibiotics unless bacterial superinfection is suspected based on clinical worsening, elevated inflammatory markers, or new infiltrates 3
- Azithromycin should not be used in the absence of bacterial infection 2
When to Seek Emergency Care
Seek immediate medical attention if you develop: 2
- Severe breathlessness or difficulty breathing
- Persistent chest pain or pressure
- New confusion or inability to stay awake
- Blue lips or face
- Oxygen saturation <94% on pulse oximetry
Special Considerations for Elderly Patients (Age >80)
- Reduce all COVID-19 medication doses to 1/2 of standard adult doses due to deteriorated liver and kidney function 5
- Consider early high-titer convalescent plasma therapy, which significantly reduces severe conversion rates in elderly patients 5
- Monitor aggressively for secondary bacterial infections and thromboembolic complications 5